Beyond B-RAF, C-RAF and A-RAF mutations are rare but can be found in lung, ovarian, pancreatic, and glioma cancers, often presenting challenges due to RAF dimerization and limited therapeutic options [16,17]. This evidence concerns the gene BRAF and glioma.